 | | DRUG: カリソプロドール | |
| エントリ |
|
|---|
| 一般名 |
カリソプロドール (JAN);
Carisoprodol (JAN/USP/INN) |
|---|
| 米国の商品 |
|
|---|
| 後発品 |
CARISOPRODOL (A-S Medication Solutions), CARISOPRODOL (A-S Medication Solutions), CARISOPRODOL (Advanced Rx Pharmacy of Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Aphena Pharma Solutions - Tennessee), CARISOPRODOL (Asclemed USA), CARISOPRODOL (Asclemed USA), CARISOPRODOL (Aurobindo Pharma Limited), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Bryant Ranch Prepack), CARISOPRODOL (Chartwell RX), CARISOPRODOL (Direct_Rx), CARISOPRODOL (Direct_Rx), CARISOPRODOL (Directrx), CARISOPRODOL (Golden State Medical Supply), CARISOPRODOL (Ingenus Pharmaceuticals), CARISOPRODOL (Medsource Pharmaceuticals), CARISOPRODOL (Northwind Pharmaceuticals), CARISOPRODOL (Nostrum Laboratories), CARISOPRODOL (NuCare Pharmaceuticals), CARISOPRODOL (NuCare Pharmaceuticals), CARISOPRODOL (Oxford Pharmaceuticals), CARISOPRODOL (PD-Rx Pharmaceuticals), CARISOPRODOL (PD-Rx Pharmaceuticals), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Proficient Rx LP), CARISOPRODOL (Quality Care Products), CARISOPRODOL (REMEDYREPACK), CARISOPRODOL (REMEDYREPACK), CARISOPRODOL (Rising Pharma Holdings), CARISOPRODOL (ScieGen Pharmaceuticals), CARISOPRODOL (Vensun Pharmaceuticals), CARISOPRODOL (Wallace Pharmaceuticals), CARISOPRODOL (Wilshire Pharmaceuticals), CARISOPRODOL TABLETS, USP, 350 MG (Granulation Technology), CARISOPRODOL TABLETS, USP, 350 MG (PD-Rx Pharmaceuticals) |
|---|
| 組成式 |
C12H24N2O4
|
|---|
| 質量 |
260.1736
|
|---|
| 分子量 |
260.33
|
|---|
| 構造式 |
|
|---|
| Simcomp |
|
|---|
| クラス |
|
|---|
| コード |
|
|---|
| 効能 |
骨格筋弛緩薬 |
|---|
| コメント |
カルバメート系
|
|---|
| 代謝 |
Enzyme: CYP2C19 [HSA: 1557]
|
|---|
| 相互作用 |
|
|---|
| 構造マップ |
|
|---|
| 階層分類 |
医療用医薬品のATC分類 [BR:jp08303]
M 筋骨格系
M03 筋弛緩薬
M03B 筋弛緩薬、中枢作用型薬剤
M03BA カルバミン酸エステル
M03BA02 カリソプロドール
D00768 カリソプロドール (JAN) <US>
医療用医薬品のUSP分類 [BR:jp08302]
骨格筋弛緩薬
カリソプロドール
D00768 カリソプロドール (JAN)
医薬品グループ [BR:jp08330]
筋骨格系用薬
DG02029 筋弛緩薬
DG01974 中枢性筋弛緩薬
DG01973 カルバメート系筋弛緩薬
D00768 カリソプロドール
代謝酵素基質薬
DG01639 CYP2C19基質薬
D00768 カリソプロドール
薬物代謝酵素とトランスポーター [jp08309.html]
薬物代謝酵素
D00768
ゲノムバイオマーカー [jp08341.html]
医薬品応答に影響を与える多型と変異
D00768
|
|---|
| リンク |
|
|---|
| LinkDB |
|
|---|
|
» English version » Back
|